Page last updated: 2024-08-21

orcinol and Bone Loss, Osteoclastic

orcinol has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gong, W; Liu, M; Qin, L; Wang, Y; Xiang, L; Zhang, Q; Zhao, Q; Zheng, C	1

Other Studies

1 other study(ies) available for orcinol and Bone Loss, Osteoclastic

Article	Year
Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway. Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Animals; Autophagy; Bone Resorption; Glucosides; Hydrogen Peroxide; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Osteoclasts; Osteoporosis; Oxidative Stress; RANK Ligand; Resorcinols; Signal Transduction; TOR Serine-Threonine Kinases	2022

Article

Year

Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.

Oxidative medicine and cellular longevity, 2022, Volume: 2022

Topics: Animals; Autophagy; Bone Resorption; Glucosides; Hydrogen Peroxide; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Osteoclasts; Osteoporosis; Oxidative Stress; RANK Ligand; Resorcinols; Signal Transduction; TOR Serine-Threonine Kinases

2022